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Abstract
Objective: Oral lichen planus (OLP) characterized by interface mucositis frequently shows
hyper-keratinization. To clarify mechanisms of excess keratinization, we investigated key mole-
cules for cornified cell envelope (CE).
Methods: Involucrin (IVL), loricrin (LOR), transglutaminase 1 (TGase 1) and transglutaminase 3
(TGase 3) were immunohistochemically examined in 20 specimens of OLP; five specimens of
buccal mucosa served as controls. Subsequently, the data were statistically analyzed.
Results: IVL in OLP was localized in the cell membrane, in contrast to its localization in the
cytoplasm in controls. No positive reaction indicative of LOR was noted in any specimens.
Although the TGase 1 localization in controls was restricted to the upper three-quarters of
the membrane, the localization in OLP was in both membrane and in the cytoplasm of full
thickness mucosal layers. The TGase 3 localization pattern was dramatically altered from
cytoplasmic to membranous in OLP.
Conclusion: Our data suggest that aberrant TGase 1 and TGase 3 localization and distribution
are closely related to hyper-keratinization in OLP. This is the first report of ectopic transgluta-
minase localization in OLP.
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Introduction
Oral lichen planus (OLP) is a chronic
inflammatory disease caused by T-lympho-
cytes, which occurs in the epithelial-
connective tissue interface. Although its
etiology has not yet been clarified, various
conditions such as genetic disorders, stress,
drug use, exposure to dental materials, or
hepatitis C virus infection are involved in
this disease.1 This disease is characterized
by the combination of its clinical and histo-
pathological features.2,3
Histologically, OLP shows hyperkerato-
sis, a thickened ortho/para-keratinized
layer constituting the clinical features of
reticular-type OLP accompanied by band-
like lymphocytic infiltration and liquefac-
tion degeneration. In OLP, keratin 13
(K13) disappears, while keratin 10 (K10),
which is localized in the keratinized squa-
mous epithelium, is abnormally expressed.4
Bloor et al. reported that mRNA expression
levels of both K1 and K10 were up-
regulated with increasing lymphocytic infil-
tration.5 Thus, excessive keratinization is a
characteristic phenomenon that represents
abnormal differentiation of the squamous
epithelium in OLP. Both the aggregation
of keratin fibers, such as K1 and K10, and
the formation of cornified cell envelope
(CE) result in keratinization. In normal epi-
dermis, CE is an insoluble 15-nm-thick
structure that forms beneath the plasma
membrane in differentiating keratinocytes.
It includes two functional parts: one com-
prises covalently cross-linked protein
(10-nm-thick) that comprises the backbone
of the envelope; the other comprises cova-
lently linked ceramide lipids (5-nm-thick).
In the early phase of CE formation, trans-
glutaminase 1 (TGase 1) and involucrin
(IVL) are expressed along with K1 and
K10 in lower keratinocytes. Subsequently,
TGase 1 cross-links IVL and intercellular
ceramide lipids on the cell membrane.
Finally, TGase 1 binds together
cross-linked IVL and loricrin (LOR)–small
proline-rich protein (SPR) complexes that
were previously combined by transglutami-
nase 3 (TGase 3).6
As described above, TGase 1 and TGase
3 are key molecules associated with CE
formation. Immunohistologically, non-
keratinizing oral epithelium shows cyto-
plasmic expression of IVL, while the
epithelium demonstrates ectopic membra-
nous localization in OLP.7 To our knowl-
edge, the mechanism of excessive
keratinization has not been determined.
To resolve this issue, we examined the local-
ization of CE-related proteins, such as IVL,
LOR, TGase 1, and TGase 3, in OLP.
Materials and methods
Case selection
We selected specimens from 130 cases from
the archives of our surgical pathology lab-
oratory that were diagnosed with OLP
during the period from 2000 to 2013. All
cases had been diagnosed in accordance
with a set of modified World Health
Organization diagnostic criteria,2,3 which
comprised clinically bilateral and lace-like
network features and histological features
of band-like lymphocytic infiltration and
liquefaction degeneration in the basal cell
layer without epithelial dysplasia. Finally,
20 specimens, which were bilateral and
reticular, and which originated from
patients without histories of drug- or
metal-induced allergy and hepatitis C virus
infection, were chosen. All OLP specimens
showed typical histopathological features
with band-like lymphocytic infiltration and
varying degrees of basal cell injury and
keratinization. Five specimens of buccal
mucosa that served as controls were
obtained from the mucosa of patients with
vascular malformation (four cases) or from
the non-cancerous portion of squamous cell
carcinoma (one case), without either of the
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following: 1) inflammatory or atypical
changes, and 2) medical histories of allergy
and hepatic infection. These control speci-
mens showed no or slight keratinization.
The average age of control and OLP
patients was 49.8 and 60.7 years,
respectively.
This study was approved by the Ethics
Committee of Matsumoto Dental
University (approval number 209) and con-
ducted according to the principles of the
Declaration of Helsinki (version 2002).
Informed consent was obtained in the
form of opt-out because all samples consti-
tuted archived paraffin-embedded tissues.
Immunohistochemistry
Deparaffinized and hydrated 3-mm-thick
sections were pretreated in accordance
with the manufacturer’s recommendations.
A high-temperature unmasking technique
was performed by autoclaving at 121C
for 15 minutes in 0.01 M sodium citrate
buffer solution (pH 6.0); some sections
were digested with proteinase K (DAKO,
Glostrup, Denmark). As shown in
Table 1, IVL (Leica Novocastra,
Newcastle, UK), LOR (GeneTex, Irvine,
CA, USA), TGase 1 (Abnova, Taipei,
Taiwan), and TGase 3 (Sigma-Aldrich, St.
Louis, MO, USA) were used as primary
antibodies. IVL, LOR, and TGase 1 were
incubated at 4C for 24 hours, while TGase
3 was incubated for 60 minutes at room
temperature. As secondary antibody,
Nichirei MAX-PO Multi (Nichirei, Tokyo,
Japan) was incubated for 30 minutes at
room temperature with HISTOSTAINERVR
(Nichirei). After visualization with
3-30-diaminobenzidine tetrahydrochloride
(DAKO), sections were counterstained
with hematoxylin. Negative control slides
were processed with phosphate-buffered
saline, rather than primary antibodies.
Subsequently, indirect immunofluorescence
was performed with the above-mentioned
primary antibodies and Alexa FluorVR 488-
conjugated F (ab’) 2-goat anti-mouse IgG
(HþL) secondary antibody (Thermo Fisher
Scientific, Waltham, MA, USA). To con-
firm co-expression of IVL and TGase 3,
Alexa FluorVR 488-conjugated F (ab’)
2-goat anti-mouse IgG (HþL) secondary
antibody and Alexa FluorVR 647-conjugated
F (ab’) 2-goat anti-rabbit IgG (HþL) sec-
ondary antibody (Thermo Fisher Scientific)
were used for indirect double immunofluo-
rescence. Immunofluorescence images
were taken with a fluorescence microscope
BZ-X710 (KEYENCE Corporation,
Osaka, Japan).
Immunohistochemical analyses of
CE-related protein reactions
After evaluation of immunoreactions, posi-
tive reactions of all antibodies were
analyzed by using two approaches, as
described below.
Intracellular localization pattern of
positive reaction
Immunostaining indicated that CE-related
proteins were either cytoplasmic or mem-
branous. Therefore, we examined the fre-
quencies of positive cases of CE-related
proteins, divided into cytoplasmic and
membranous patterns. Sporadic/faint posi-
tive reactions and positive reactions in more
than half of the cells in any layers were
Table 1. Panel of antibodies used.
Antibody Clone Company Dilution Pretreatment
IVL SY5 Novocastra 1:100 ProK#
LOR – GeneTex 1:500 ProK#
TGase1 – Abnova 1:160 ProK#
TGase3 – SIGMA 1:200 HRM*
IVL: Involucrin, LOR: loricrin, TGase1: transglutaminase 1,
TGase3: transglutaminase 3.
*Heat antigen-retrieval method, #Proteinase K digestion.
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designated as “negative” and “positive,”
respectively. Positive cases per all cases
examined were calculated as values (%).
Intraepithelial distribution patterns of
positive reactions
We also examined the extent of CE-related
proteins in the epithelium of control and
OLP specimens. The epithelium was equally
divided into quarters from upper to lower
(superior, upper middle, lower middle, and
inferior parts). On the basis of immunostain-
ing results, the distribution patterns of
immunoreactions were classified into four
types: upper quarter (1/4), upper half (1/2),
upper three-quarters (3/4), and full thickness
(4/4) patterns. Values (%) were numbers of
each pattern per numbers of cases.
Statistical analysis
To compare values between control and
OLP specimens, values of localization and
distribution patterns were analyzed by
using Fisher’s exact test and corrected by
Holm’s method. All were analyzed with
EZR (Saitama Medical Center, Jichi
Medical University, Saitama, Japan),
which is a graphical user interface for R
(www.r-project.org).8
Results
Immunohistochemical reactions of
CE-related proteins
In controls, positive reactions indicative of
IVL and TGase 3 localization were mostly
found in the cytoplasm surrounding perinu-
clear areas, while TGase 1 was limited to
the membrane. In OLP specimens, all anti-
bodies (with the exception of LOR) showed
varying degrees and frequencies of both
membranous and cytoplasmic-positive
reactions (Figure 1). The nuclear positive
reaction of TGase 3 was consistently noted
in the middle portions of both control and
OLP specimens (Figure 1c). LOR reactions
were negative in all layers of all specimens
examined (data not shown). There were no
verifiable reactions in negative controls
among all examined antibodies.
Double immunofluorescence images
demonstrated cytoplasmic expression of
both IVL and TGase 3 in controls. In con-
trast, OLP specimens showed co-expression
of IVL and TGase 3 on the membrane
(Figure 2).
Intracellular localization patterns of
positive reaction
IVL was localized in the cytoplasm in all
controls, but in only 20.0% of OLP speci-
mens. Conversely, membranous IVL-
positive reactions were noted in 80.0% of
OLP specimens, but in no control speci-
mens. There were no cytoplasmic TGase 1
reactions in controls, whereas 70.0% of
OLP specimens were membranous-
positive. Membranous reactivity of TGase
1 was consistently observed in all control
and OLP specimens. In contrast, cytoplas-
mic TGase 3 immunoreactivity was demon-
strated in all control specimens, whereas
only 15% of OLP specimens exhibited cyto-
plasmic TGase 3; 85% of OLP specimens
showed membranous TGase 3 localization,
but this was absent among controls. With
the exception of LOR and membranous
TGase 1, all differences were statistically
significant (p< 0.01 or less) between control
and OLP specimens (Table 2).
Intraepithelial distribution patterns of
positive reactions
Although most cases showed upper three-
quarter or full thickness patterns among
both control and OLP specimens, there
were some exceptional patterns of IVL
and TGase 3 distribution that showed a ten-
dency toward restriction in the upper parts
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Figure 1. Immunohistochemistry of CE-related proteins: IVL is cytoplasmic-positive in the upper portion
of the spinous layer of control specimens (a1), and membranous-positive in the full thickness layers of OLP
specimens (a2). TGase 1 in control specimens is membranous-positive from the middle spinous to the
superficial layers (b1). TGase 1 in OLP specimens is cytoplasmic-positive in the lower portion, in addition
to a membranous-positive reaction from basal to spinous layers (b2). TGase 3 in control specimens is
nuclear- and cytoplasmic-positive from lower spinous to superficial layers (c1). In OLP specimens, TGase 3 is
nuclear-, cytoplasmic-, and membranous-positive from middle spinous to superficial layers (c2). All bars are
100 lm and all inserted figures are high-magnified views of immunofluorescence.
CE: cornified cell envelope, IVL: Involucrin, OLP: oral lichen planus, TGase1: transglutaminase 1, TGase3:
transglutaminase 3.
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(Table 2). The distributions of TGase 1 sig-
nificantly differed (p<0.001) between con-
trol and OLP specimens, but those of IVL
and TGase 3 did not.
Discussion
In this study, we showed altered localiza-
tion patterns of IVL, TGase 1, and TGase
3 between specimens from OLP cases and
controls. The reticulo-white type of OLP,
according to Andreasen’s classification,
shows various histopathological changes,
including saw-tooth appearance, acantho-
sis, and acceleration of keratinization, in
addition to band-like T cell infiltration.1
Excessive keratinization is a characteristic
phenomenon representing abnormal differ-
entiation of the squamous epithelium
in OLP. Therefore, understanding the
Table 2. Immunoreactive patterns.
Antibody Specimen
Intracellular localization Intraepithelial distribution
Cytoplasmic Membranous Upper 1/4 Upper 1/2 Upper 3/4 Full 4/4
IVL Cont 100.0 0.0 0.0 0.0 40.0 60.0
OLP 20.0*** 80.0** 2.5 5.0 5.0 87.5
LOR Cont 0.0 0.0 0.0 0.0 0.0 0.0
OLP 0.0 0.0 0.0 0.0 0.0 0.0
TGase1 Cont 0.0 100.0 0.0 0.0 100.0 0.0
OLP 70.0** 100.0 0.0 0.0 17.5*** 82.5***
TGase3 Cont 100.0 0.0 0.0 0.0 40.0 60.0
OLP 15.0 *** 85.0** 5.0 12.5 32.5 50.0
IVL: Involucrin, LOR: loricrin, OLP: oral lichen planus, TGase1: transglutaminase 1, TGase3: transglutaminase 3
Upper 1/4：upper quarter pattern, Upper 1/2: upper half pattern, Upper 3/4: upper three-quarters pattern, Full 4/4: full
thickness pattern.
Values represent numbers of each pattern per numbers of cases (%). **p<0.01, ***p<0.001.
Figure 2. Co-expression of IVL and TGase 3 in OLP: Double immunofluorescence for IVL and TGase 3
reveals no yellowish membranous reactions in control specimens (a). In OLP specimens, an overlay image of
IVL and TGase 3 shows yellowish membranous reactions distributed through the upper-half of the spinous
layer (b). All bars are 100 lm and all inserted figures are high-magnified views.
IVL: Involucrin, OLP: oral lichen planus, TGase1: transglutaminase 1, TGase3: transglutaminase 3.
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mechanism of this status is important for
clarifying this complex disease, and it is crit-
ical to determine the key to abnormal
keratinization.
IVL was reported to localize aberrantly
on the cell membrane in OLP.7 This ectopic
localization is consistent with the cross-
linkage of IVL after transfer to the cell
membrane in the early phase of CE
formation of epidermal keratinocytes.9
Specifically, unless IVL transfers to the
membrane, CE cannot be formed in kerati-
nocytes. The buccal mucosa used as control
in our study showed only cytoplasmic IVL
expression, which appears to represent typ-
ical non-keratinizing squamous epithelium.
Importantly, there was a statistically signif-
icant increase in the frequency of membra-
nous localization in OLP. Transfer of IVL
to the membrane in 80% of OLP speci-
mens, which mimics IVL localization in
the epidermis, may be a cause of excess
keratinization in the inflamed buccal
mucosa. Therefore, proteins that contribute
to membranous localization of IVL may be
important in supporting excess keratiniza-
tion in OLP.
Although it was not statistically signifi-
cant, the pattern of IVL localization in OLP
specimens was 87.5% full thickness, com-
pared with 60% full thickness in control
specimens. Similar to our results,
McCullough and Radden reported that
the IVL-positive area maximally increased
when the grades of lymphocytic infiltration
and epithelial injury were highest.7 The phe-
nomenon of IVL expression in the lower
epithelium is thought to derive from the
scraping of lower epithelial cells, such as
basal and parabasal cells. EGFR induces
IVL production,10 such that IVL might be
widely expressed as a result of chronic
inflammatory reaction. However, IVL
cannot accelerate keratinization alone.
After IVL cross-linkage to the cell mem-
brane, the complex of LOR and SPRs,
bound by TGase 3, transfers to the cell
membrane, reinforcing the CE.11 In this
study, LOR was absent in both buccal
mucosa and OLP. Epidermal keratinocytes
exhibit greater expression of LOR than
SPRs,9 while LOR is a minor component
in oral keratinocytes.12 Therefore, the neg-
ative staining results could be related to an
extremely small amount of LOR. Excess
keratinization of OLP might be influenced
by other proteins, rather than by LOR.
TGase 1 and TGase 3 are important
enzymes for cross-linking CE-related pro-
teins, such as IVL and LOR.11 In cutaneous
keratinocytes, soluble-type TGase 1 local-
ized in the cytoplasm is the precursor of a
TGase 1 with weak enzymatic activity.13–15
After partial degradation and anchoring
to the cell membrane, TGase 1 activity
increases.16–18 In in vitro studies, human
epidermal keratinocytes exhibited TGase 1
and TGase 3 that were restrictively degrad-
ed by calcium-dependent cytoplasmic pro-
teases, such as m/m-calpains.14 According to
quantitative analysis in the foreskin, the
undegraded or full-length form of TGase
1 is the dominant form of TGase 1 in
basal cells, while the degraded complex-
form of TGase 1 is dominant in upper ker-
atinocytes.13,15 This evidence suggests that a
small amount of active TGase 1 is also pre-
sent and active in basal and parabasal cells.
Therefore, the expression of TGase 1 and
TGase 3 in the lower portion of the epithe-
lium could be meaningful for both cross-
linking and transferring of IVL.
The localization patterns of TGase 1 also
differed between control and OLP speci-
mens. In contrast to the controls that
showed only a membranous pattern,
TGase 1 in 70% of OLP specimens was
localized on the membrane and in the cyto-
plasm of basal to spinous layers. These
results showed that the cytoplasmic or
full-length form of TGase 1 is expressed
and contributes to cross-linking and trans-
ferring of IVL in basal and parabasal cells,
as mentioned above. Considering the
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TGase 1 expression pattern in skin (i.e., in
the cytoplasm of basal to spinous layers,
and in the membrane of the upper epider-
mis),13 it seems that the TGase 1 expression
in OLP closely resembles that of the epider-
mis. Thus, cytoplasmic TGase 1 in basal
layers accelerates IVL membrane transfer;
consequently, IVL in OLP indicates the epi-
dermal type localization.
Although the distribution patterns of
TGase 3 did not significantly differ between
control and OLP specimens, the TGase 3
localization pattern was dramatically
altered, from cytoplasmic to membranous,
in 85% of OLP specimens, which is substan-
tially different from that of epidermal TGase
3. Interestingly, this abnormal change has
not been previously reported. With respect
to epidermal CE formation, TGase 3 that is
unanchored to the cell membrane promotes
the formation of intra-chain cross-links in
LOR and cross-links between LOR and
SPRs; however, it only participates in the
early phase of CE assembly in the cyto-
plasm.9,12,19 The biological function of mem-
branous TGase 3 is an important question,
but has not been resolved in oral epithelium.
Immunofluorescence microscopy clearly
revealed co-expression of TGase 3 and
IVL, which suggests that TGase 3 anchoring
occurs in the cell membrane in OLP.
The precise role of TGase 3 is unknown,
but we suspect that membranous localiza-
tion of TGase 3 contributes to hyper-
keratinization in OLP.
Although numerous reports have been
published regarding TGase or CE forma-
tion, only limited data have been provided
to resolve the mechanisms of excess kerati-
nization in oral diseases. Curro` et al.20
reported that mRNA expression levels of
TGASE1 and TGASE3 were significantly
reduced in the gingival epithelium of chron-
ic periodontitis patients, compared with
healthy controls. Reduced mRNA expres-
sion is generally consistent with pathologi-
cal conditions, in that the inflamed
epithelium shows degenerative and necrotic
changes. Notably, similar alteration of
mRNA expression might be observed in
erosive-type OLP. As shown in an in vitro
experiment, a lower growth rate was asso-
ciated with reduced expression of differen-
tiation markers, such as involucrin and
filaggrin, whereas overexpression of wild-
type TGASE1 led to accelerated growth.21
Interestingly, phenotypic analysis with
TGase1 and TGase2 double-knockout
mice showed that absence of the TGase1
gene resulted in defective CE assembly
and keratinization.22 Considering these
reports, TGase 1 and TGase 3 appear to
be crucial for keratinization and differenti-
ation of keratinocytes. To resolve the pre-
cise roles of TGase 1 and TGase 3 in
reticulo-white type OLP, mRNA expression
and regulatory genes, including AP1, AP2,
Sp1, Ets, and POU,23 should be examined.
In conclusion, our study clearly showed
altered localization patterns, from membra-
nous to both membranous and cytoplasmic
in widely distributed TGase 1, and from
cytoplasmic to membranous in TGase 3.
Thus, the distribution of abnormal trans-
glutaminases in buccal-mucosal epithelium
promotes membranous IVL translocation,
resulting in hyperkeratosis. This is the first
report of the ectopic localization of TGase
1 and TGase 3 in OLP.
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